Improving health services for young women through private drug shops
Effects of a prosocial intervention among sellers of HIV and reproductive health supplies on young women’s health
This study is working to make it easier for young women in sub-Saharan Africa to get HIV tests and contraception by partnering with local drug shops, using a friendly loyalty program to encourage shopkeepers to offer these important health services.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10706507 on NIH RePORTER |
What this research studies
This research focuses on enhancing access to HIV testing and contraception for adolescent girls and young women in sub-Saharan Africa by leveraging private sector drug shops. The study aims to implement a loyalty program called Malkia Klabu, which encourages shopkeepers to provide these essential health services. By using strategies that motivate shopkeepers through customer feedback, the research seeks to ensure that young women can discreetly obtain reproductive health supplies. The approach is designed to address the barriers that prevent young women from accessing critical health services.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls and young women aged 15-24 living in sub-Saharan Africa who are at risk of unintended pregnancy and HIV.
Not a fit: Patients outside the age range of 15-24 or those not residing in sub-Saharan Africa may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the availability and uptake of HIV prevention and reproductive health services for young women.
How similar studies have performed: Previous pilot studies, such as the Malkia Klabu intervention in Tanzania, have shown promising results in increasing access to health services for young women.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Liu, Jenny Xin — University of California, San Francisco
- Study coordinator: Liu, Jenny Xin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.